SeanKalraMD

Critical Care Medicine

Physician

Dr. Kalra is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Sean Kalra, MD, is a pulmonologist specializing in critical care medicine based in Boston, MA. He completed medical school at the University of Colorado School of Medicine in 2017, followed by an internal medicine residency at Yale-New Haven Medical Center from 2017 to 2020. He then pursued a fellowship in pulmonary disease and critical care medicine at Brigham and Women's Hospital, from 2021 to 2024. Dr. Kalra is also advancing his education with an MPH in Quantitative Methods at Harvard TH Chan School of Public Health (2023-2025). His research work includes several publications in reputable journals such as the American Journal of Respiratory and Critical Care Medicine and Oncogene.

Harvard TH Chan School of Public HealthMPH, Quantitative Methods, 2023 - 2025
Brigham and Women's HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2021 - 2024
Yale-New Haven Medical CenterResidency, Internal Medicine, 2017 - 2020
University of Colorado School of Medicine Anschutz Medical CampusClass of 2017

PubMed

The Association of Interstitial Lung Abnormalities and Preserved Ratio Impaired Spirometry Findings With Mortality.
Sean Kalra, Brian Hobbs, Gary M Hunninghake, Aravind A Menon, Rachel Putman
Chest. 2025-02-11
1 citations
Development, Progression, and Mortality of Suspected Interstitial Lung Disease in COPDGene.
Jonathan A Rose, Ann-Marcia C Tukpah, Claire Cutting, Noriaki Wada, Mizuki Nishino
American Journal of Respiratory and Critical Care Medicine. 2024-12-15
Who Modifies the Modifiers: A High-Resolution View of the Genetic Modifiers of Cystic Fibrosis.
Sean Kalra, Michael H Cho
American Journal of Respiratory and Critical Care Medicine. 2023-05-15

Journal Articles

SMAD4 Loss promotes lung cancer formation but increases sensitivity to DNA topoisomerase inhibitors
SM Haeger, JJ Thompson, S Kalra, TG Cleaver, D Merrick, X-J Wang, SP Malkoski, Oncogene, 4/20/2015

Abstracts/Posters

Determining the Optimal Alcohol Screening Questionnaire in the Medical ICU
S Kalra, I Douglass, EL Burnham, K Reed, M Moss, BJ Clark, American Thoracic Society, Denver, CO, 5/17/2015